Background: Eicosapenaenoic acid (EPA) has immune-modulating effects and may improve nutritional status in cancer especially in relation to its role in tumour cachexia. The aim ofthe study was to evaluate the efficacy of administration eicosapentaenoic acid for increasing the CD8+ of the stadium IIIB invasive ductus breast cancer patients underwent the first cycle chemotherapy with Cyclophospha…